Bill Ackman’s Equity Portfolio Moves During Q4

In a 13F filing, Pershing Square, managed by Bill Ackman, disclosed its holdings for the last quarter of 2013. Bill Ackman is a long term value investor, who takes advantage of short term downward moves in prices, and has a very concentrated portfolio. The value of Bill Ackman’s equity portfolio fell to $8.23 billion in the fourth quarter, from $10.28 billion in the previous quarter. Let’s take a look at the fund’s top five stock picks.

Bill Ackman in crowd

The first on the list is Canadian Pacific Railway Limited (USA) (NYSE:CP), in which the fund trimmed its stake to 17.16 million shares from 23.13 million shares held in the previous quarter. The value of the current holding is $2.59 million. The fund reported reducing the stake in Canadian Pacific in October.

Air Products & Chemicals, Inc. (NYSE:APD) is the second largest position in the fund’s equity portfolio. The fund owns 20.55 million shares of the company, with a reported value of $2.29 million. The position remained almost unchanged compared to the previous quarter.

In BEAM Inc (NYSE:BEAM) a premium spirits company, Pershing Square’s holding remained almost unchanged at 20.82 million shares. The value of the position, however, increased to $1.42 billion from $1.35 billion at the end of the third quarter.

Standing on the fourth spot is Burger King Worldwide Inc (NYSE:BKW), a fast food hamburger restaurant. The fund revealed holding 38.39 million shares of the company with a reported value of $877.55 million.

The fifth most valuable holding of Pershing Square is General Growth Properties Inc (NYSE:GGP), a real estate investment trust. The fund sliced its holding to 27.62 million shares from 35.68 million shares held in the previous quarter. The value of the current holding is $554.42 million.

Last month, Bill Ackman revealed, adding 29.1 million shares of Platform Specialty Products Corporation (NYSE:PAH) to its equity portfolio, but this holding was not disclosed in the latest 13F.

Disclosure: none

Recommended reading:

Billionaire Ken Griffin’s New Stock Moves

Nelson Peltz’s Trian Fund Bets on Mondelez and PepsiCo Among Others

Billionaire Stan Druckenmiller’s Top Stock Picks

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!